ArticleFrontiers in immunology2026

A compass in the challenge: the CALLY index as a prognostic biomarker in advanced cholangiocarcinoma treated with chemoimmunotherapy: a retrospective propensity score-matched cohort study.

Runjia Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.